1 Chew EY, "The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes : the Action to Control Cardiovascular Risk in Diabetes(ACCORD)Eye Study" 121 : 2443-2451, 2014
2 Kim NH, "Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy : a population-based study" 44 : 361-367, 2018
3 정유리, "Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World- Based Cohort Study" 대한당뇨병학회 43 (43): 640-648, 2019
4 Deacon CF, "Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas" 18 : 333-347, 2016